Moderated by Franklin Institute Chief Bioscientist Dr. Jayatri Das
Thursday, May 13, 2021 - 7:00pm
Clinical trials are key to ensuring new medicines are safe and effective. Racial and ethnic minorities have historically been underrepresented in clinical trials and continue to be, for reasons ranging from access to mistrust. As medicine rapidly advances, it's increasingly important to close the diversity gap in clinical trials to tackle current health disparities and ensure marginalized communities can benefit from the medical breakthroughs of the future. However, barriers to participation remain, and sustainable solutions are long overdue.
From the ethics of designing research to new strategies for improving reach and access—meet individuals actively working on solutions for a more equitable future, and hear perspectives gathered in advance from the community-at-large in a special live event moderated by Franklin Institute Chief Bioscientist Jayatri Das, Ph.D., featuring:
• Eric Kmiec, Ph.D., Director of the Gene Editing Institute (GEI) at ChristianaCare Health System
• Jacqueline Crawford, ChristianaCare Health System nurse and participant in cancer research
• Anya Harry, M.D., Ph.D., Global Lead Clinical Trial Diversity at GlaxoSmithKline
• Holly Fernandez Lynch, Assistant Professor of Medical Ethics, Perelman School of Medicine, University of Pennsylvania